Naiarabrocal Pneumology ERS Congress The long list of health benefits, demonstrated or still only associated with the family of GLP-1 agonists, could add the respiratory ones.A new study presented at the Congress of the European Respiratory Society (ERS), held in Barcelona, links the use of these drugs for diabetes and obesity with a reduction of almost 40% of asthma attacks and 20% of COPD exacerbations.The research, led by Chloe Bloom, profess…